NCT06324747

Brief Summary

This study compare between the vestibular socket therapy (VST) and the traditional mucoperiosteal flap reflection in immediate implant placement in type II extraction socket in the esthetic zone. The technique of vestibular socket therapy (VST), introduced by Elaskry, enables the placement of implants immediately while simultaneously rehabilitating the entire socket, resulting in excellent esthetic and functional outcomes that meet the expectations of patients. VST involves socket augmentation through a minimally invasive vestibular access incision, eliminating the need for the traditional mucoperiosteal flap reflection, regardless of the extent of socket compromise.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 23, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 4, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

March 22, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

August 22, 2025

Status Verified

August 1, 2025

Enrollment Period

11 months

First QC Date

December 4, 2023

Last Update Submit

August 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Soft Tissue Stability

    it will be measured digitally using the intraoral scanner. A preoperative scanning, immediate postoperative, 2 months postoperative and 8 months postoperative scanning will be done. Tool to be used: 3shape trios 4 what will be assessed: * gingival recession * loss of interdental papillae height Data will be measured in millimeters

    8 months

Secondary Outcomes (1)

  • Bone Regeneration

    8 months

Other Outcomes (1)

  • Pink Esthetic Score (PES)

    8 months

Study Arms (2)

Control group

OTHER

Control group will have a full thickness flap, followed by an immediate implant placement using a surgical guide. Then a guided bone regeneration will be achieved by bone graft (autogenous bone chips and xenograft particles and a membrane barrier 1 mm thickness will be applied. The membrane shield then will be stabilized to the apical bone using 2 membrane tacks, customized healing abutment will be connected , then, the elevated flap will be sutured to its original position.

Procedure: conventional full thickness flap

Test group

ACTIVE COMPARATOR

Elaskary Vestibular socket therapy instruments will be used for the intervention, A 1 cm long vestibular access incision at the allocated hopeless tooth will be made at the base of the hopeless tooth to the adjacent teeth. The vestibular pouch will then be dissected in an incisal direction exposing the total socket area and allowing direct access to the socket environment. An immediate implant will be installed using a surgical guide. A membrane shield 1 mm thick will be, trimmed, and tucked through the vestibular access incision starting at 1 mm beyond the socket orifice and reaching to the apical area of the socket. The gap and/ or the defect between the implant body and the shield will then be filled with the same grafting components so the control group. Finally, the vestibular incision will be secured with sutures. The socket will be sealed with a customized healing abutment.

Procedure: Vestibular socket therapy

Interventions

Vestibular socket therapy will be used for the intervention.

Also known as: VST
Test group

reflecting the mucoperiosteum to access the extraction socket

Control group

Eligibility Criteria

Age21 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Hopeless maxillary tooth in the esthetic region missing coronal tooth structure
  • Type II socket (deficient labial plate of bone and intact overlying soft tissues)
  • Adequate palatal bone, ≥ 3 mm apical bone to engage the immediately placed implants

You may not qualify if:

  • Smokers
  • Pregnant women
  • Patients with systemic diseases
  • History of chemotherapy or radiotherapy within the past 2 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The British university in Egypt

Cairo, New Cairo, Egypt

Location

Study Officials

  • Mohamed Shawky, BDS

    The British University in Egypt

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Due to the differences in techniques, the operating surgeon can not be blinded to the procedure
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two equal parallel groups with a 1:1 allocation ratio to receive either vestibular socket therapy (test group) or to be treated with conventional mucoperiosteal flap (control group).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dentist (BDS)

Study Record Dates

First Submitted

December 4, 2023

First Posted

March 22, 2024

Study Start

October 23, 2023

Primary Completion

October 1, 2024

Study Completion

December 1, 2024

Last Updated

August 22, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share
Shared Documents
SAP

Locations